{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T17:10:20Z","timestamp":1740157820931,"version":"3.37.3"},"reference-count":37,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2020.11504","type":"journal-article","created":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T08:55:02Z","timestamp":1585731302000},"source":"Crossref","is-referenced-by-count":3,"title":["Inhibition of miR\u201118a\u20113p reduces proliferation of mesothelioma cells and sensitizes them to cisplatin"],"prefix":"10.3892","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2307-2643","authenticated-orcid":false,"given":"Rui","family":"Suzuki","sequence":"first","affiliation":[{"name":"Department of Pathology, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima 734\u20118551, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4986-2109","authenticated-orcid":false,"given":"Vishwa","family":"Amatya","sequence":"additional","affiliation":[{"name":"Department of Pathology, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima 734\u20118551, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2474-5969","authenticated-orcid":false,"given":"Kei","family":"Kushitani","sequence":"additional","affiliation":[{"name":"Department of Pathology, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima 734\u20118551, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichiro","family":"Kai","sequence":"additional","affiliation":[{"name":"Department of Pathology, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima 734\u20118551, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Kambara","sequence":"additional","affiliation":[{"name":"Department of Pathology, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima 734\u20118551, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaro","family":"Fujii","sequence":"additional","affiliation":[{"name":"Department of Pathology, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima 734\u20118551, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukio","family":"Takeshima","sequence":"additional","affiliation":[{"name":"Department of Pathology, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima 734\u20118551, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2020,4,1]]},"reference":[{"key":"key20220302131453_b1-ol-0-0-11504","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1038\/bjc.2013.514","article-title":"The latency period of mesothelioma among a cohort of British asbestos workers (1978\u20132005)","volume":"109","author":"Frost","year":"2013","journal-title":"Br J Cancer"},{"key":"key20220302131453_b2-ol-0-0-11504","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/sj.bjc.6690105","article-title":"The European mesothelioma epidemic","volume":"79","author":"Peto","year":"1999","journal-title":"Br J Cancer"},{"key":"key20220302131453_b3-ol-0-0-11504","doi-asserted-by":"publisher","first-page":"197","DOI":"10.2486\/indhealth.MS1184","article-title":"Future trends of mesothelioma mortality in Japan based on a risk function","volume":"50","author":"Myojin","year":"2012","journal-title":"Ind Health"},{"key":"key20220302131453_b4-ol-0-0-11504","doi-asserted-by":"publisher","first-page":"3239","DOI":"10.1007\/s00268-019-05132-6","article-title":"Largely Unchanged annual incidence and overall survival of pleural mesothelioma in the USA","volume":"43","author":"Keshava","year":"2019","journal-title":"World J Surg"},{"key":"key20220302131453_b5-ol-0-0-11504","first-page":"179","article-title":"Asbestos in developing countries: Magnitude of risk and its practical implications","volume":"17","author":"Joshi","year":"2004","journal-title":"Int J Occup Med Environ Health"},{"key":"key20220302131453_b6-ol-0-0-11504","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","article-title":"Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma","volume":"21","author":"Vogelzang","year":"2003","journal-title":"J Clin Oncol"},{"key":"key20220302131453_b7-ol-0-0-11504","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: Genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"key":"key20220302131453_b8-ol-0-0-11504","doi-asserted-by":"publisher","first-page":"E1611","DOI":"10.3390\/ijms20071611","article-title":"The roles of MicroRNA in lung cancer","volume":"20","author":"Wu","year":"2019","journal-title":"Int J Mol Sci"},{"key":"key20220302131453_b9-ol-0-0-11504","doi-asserted-by":"publisher","first-page":"E1510","DOI":"10.3390\/ijerph16091510","article-title":"MicroRNA in ovarian cancer: Biology, pathogenesis, and therapeutic opportunities","volume":"16","author":"Chen","year":"2019","journal-title":"Int J Environ Res Public Health"},{"key":"key20220302131453_b10-ol-0-0-11504","doi-asserted-by":"publisher","first-page":"7639084","DOI":"10.1155\/2017\/7639084","article-title":"MicroRNA in glioblastoma: An overview","volume":"2017","author":"Banelli","year":"2017","journal-title":"Int J Genomics"},{"key":"key20220302131453_b11-ol-0-0-11504","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.3892\/ijo.2016.3358","article-title":"Differential microRNA expression profiling of mesothelioma and expression analysis of miR-1 and miR-214 in mesothelioma","volume":"48","author":"Amatya","year":"2016","journal-title":"Int J Oncol"},{"key":"key20220302131453_b12-ol-0-0-11504","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.yexcr.2014.03.009","article-title":"miR-18a regulates the proliferation, migration and invasion of human glioblastoma cell by targeting neogenin","volume":"324","author":"Song","year":"2014","journal-title":"Exp Cell Res"},{"key":"key20220302131453_b13-ol-0-0-11504","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.bbrc.2016.06.034","article-title":"miR-18a promotes cell proliferation of esophageal squamous cell carcinoma cells by increasing cylin D1 via regulating PTEN-PI3K-AKT-mTOR signaling axis","volume":"477","author":"Zhang","year":"2016","journal-title":"Biochem Biophys Res Commun"},{"key":"key20220302131453_b14-ol-0-0-11504","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13578-018-0221-7","article-title":"TP53TG1 enhances cisplatin sensitivity of non-small cell lung cancer cells through regulating miR-18a\/PTEN axis","volume":"8","author":"Xiao","year":"2018","journal-title":"Cell Biosci"},{"key":"key20220302131453_b15-ol-0-0-11504","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1111\/j.1349-7006.2006.00184.x","article-title":"Establishment and characterization of four malignant pleural mesothelioma cell lines from Japanese patients","volume":"97","author":"Usami","year":"2006","journal-title":"Cancer Sci"},{"key":"key20220302131453_b16-ol-0-0-11504","doi-asserted-by":"publisher","first-page":"265","DOI":"10.2144\/000113083","article-title":"TScratch: A novel and simple software tool for automated analysis of monolayer wound healing assays","volume":"46","author":"Geb\u00e4ck","year":"2009","journal-title":"Biotechniques"},{"key":"key20220302131453_b17-ol-0-0-11504","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"key20220302131453_b18-ol-0-0-11504","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.cell.2009.02.005","article-title":"MicroRNAs and cancer: Short RNAs go a long way","volume":"136","author":"Ventura","year":"2009","journal-title":"Cell"},{"key":"key20220302131453_b19-ol-0-0-11504","doi-asserted-by":"publisher","first-page":"478","DOI":"10.3389\/fgene.2019.00478","article-title":"The potential for microRNA therapeutics and clinical research","volume":"10","author":"Hanna","year":"2019","journal-title":"Front Genet"},{"key":"key20220302131453_b20-ol-0-0-11504","doi-asserted-by":"publisher","first-page":"12","DOI":"10.2174\/2211536605666160128151018","article-title":"Prognostic and therapeutic implications of MicroRNA in malignant pleural mesothelioma","volume":"5","author":"Truini","year":"2016","journal-title":"Microrna"},{"key":"key20220302131453_b21-ol-0-0-11504","doi-asserted-by":"publisher","first-page":"650","DOI":"10.3389\/fonc.2018.00650","article-title":"MicroRNAs for the diagnosis and management of malignant pleural mesothelioma: A literature review","volume":"8","author":"Lo Russo","year":"2018","journal-title":"Front Oncol"},{"key":"key20220302131453_b22-ol-0-0-11504","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.jtho.2017.10.016","article-title":"Dysregulated expression of the microRNA miR-137 and its target YBX1 contribute to the invasive characteristics of malignant pleural mesothelioma","volume":"13","author":"Johnson","year":"2018","journal-title":"J Thorac Oncol"},{"key":"key20220302131453_b23-ol-0-0-11504","doi-asserted-by":"publisher","first-page":"23480","DOI":"10.18632\/oncotarget.4346","article-title":"miR-193a-3p is a potential tumor suppressor in malignant pleural mesothelioma","volume":"6","author":"Williams","year":"2015","journal-title":"Oncotarget"},{"key":"key20220302131453_b24-ol-0-0-11504","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.3892\/ijo.2017.3863","article-title":"PIM1 knockdown inhibits cell proliferation and invasion of mesothelioma cells","volume":"50","author":"Mawas","year":"2017","journal-title":"Int J Oncol"},{"key":"key20220302131453_b25-ol-0-0-11504","doi-asserted-by":"publisher","first-page":"446","DOI":"10.3389\/fonc.2018.00446","article-title":"miR-182 and miR-183 promote cell proliferation and invasion by targeting FOXO1 in mesothelioma","volume":"8","author":"Suzuki","year":"2018","journal-title":"Front Oncol"},{"key":"key20220302131453_b26-ol-0-0-11504","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.1002\/1878-0261.12386","article-title":"Post-transcriptional regulation of PIAS3 expression by miR-18a in malignant mesothelioma","volume":"12","author":"He","year":"2018","journal-title":"Mol Oncol"},{"key":"key20220302131453_b27-ol-0-0-11504","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1002\/1878-0261.12150","article-title":"A link between the fibroblast growth factor axis and the miR-16 family reveals potential new treatment combinations in mesothelioma","volume":"12","author":"Schelch","year":"2018","journal-title":"Mol Oncol"},{"key":"key20220302131453_b28-ol-0-0-11504","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1016\/S1470-2045(17)30621-6","article-title":"Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: A first-in-man, phase 1, open-label, dose-escalation study","volume":"18","author":"van Zandwijk","year":"2017","journal-title":"Lancet Oncol"},{"key":"key20220302131453_b29-ol-0-0-11504","doi-asserted-by":"publisher","first-page":"5311","DOI":"10.1038\/sj.onc.1202998","article-title":"The INK4 family of cell cycle inhibitors in cancer","volume":"18","author":"Roussel","year":"1999","journal-title":"Oncogene"},{"key":"key20220302131453_b30-ol-0-0-11504","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1034\/j.1600-0463.2003.1110129.x","article-title":"Deregulation of the G1\/S-phase control in human testicular germ cell tumours","volume":"111","author":"Bartkova","year":"2003","journal-title":"APMIS"},{"key":"key20220302131453_b31-ol-0-0-11504","doi-asserted-by":"publisher","first-page":"e58227","DOI":"10.1371\/journal.pone.0058227","article-title":"Polypyrimidine tract-binding protein induces p19(Ink4d) expression and inhibits the proliferation of H1299 cells","volume":"8","author":"Lin","year":"2013","journal-title":"PLoS One"},{"key":"key20220302131453_b32-ol-0-0-11504","first-page":"1607","article-title":"MicroRNA-362-5p enhances the cisplatin sensitivity of gastric cancer cells by targeting suppressor of zeste 12 protein","volume":"18","author":"Wei","year":"2019","journal-title":"Oncol Lett"},{"key":"key20220302131453_b33-ol-0-0-11504","first-page":"885","article-title":"MicroRNA-613 induces the sensitivity of gastric cancer cells to cisplatin through targeting SOX9 expression","volume":"11","author":"Xue","year":"2019","journal-title":"Am J Transl Res"},{"key":"key20220302131453_b34-ol-0-0-11504","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.trsl.2015.11.006","article-title":"MicroRNA 25, microRNA 145, and microRNA 210 as biomarkers for predicting the efficacy of maintenance treatment with pemetrexed in lung adenocarcinoma patients who are negative for epidermal growth factor receptor mutations or anaplastic lymphoma kinase translocations","volume":"170","author":"Shi","year":"2016","journal-title":"Transl Res"},{"key":"key20220302131453_b35-ol-0-0-11504","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.omtn.2017.07.001","article-title":"MicroRNA-31 regulates chemosensitivity in malignant pleural mesothelioma","volume":"8","author":"Moody","year":"2017","journal-title":"Mol Ther Nucleic Acids"},{"key":"key20220302131453_b36-ol-0-0-11504","doi-asserted-by":"publisher","first-page":"5319","DOI":"10.1038\/onc.2013.476","article-title":"Protumorigenic effects of mir-145 loss in malignant pleural mesothelioma","volume":"33","author":"Cioce","year":"2014","journal-title":"Oncogene"},{"key":"key20220302131453_b37-ol-0-0-11504","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.3892\/or.2014.3481","article-title":"miR-379\/411 cluster regulates IL-18 and contributes to drug resistance in malignant pleural mesothelioma","volume":"32","author":"Yamamoto","year":"2014","journal-title":"Oncol Rep"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2022,3,2]],"date-time":"2022-03-02T11:15:03Z","timestamp":1646219703000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2020.11504"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,1]]},"references-count":37,"URL":"https:\/\/doi.org\/10.3892\/ol.2020.11504","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"type":"print","value":"1792-1074"},{"type":"electronic","value":"1792-1082"}],"subject":[],"published":{"date-parts":[[2020,4,1]]}}}